Why Chinese Fentanyl Factories Are Making Peptides Now
Chinese chemical manufacturers once central to the global fentanyl crisis are now pivoting to supply a booming, unregulated U.S. market for experimental peptides, leveraging the same smuggling tactics and profit motives with little legal consequence. This shift reveals deep vulnerabilitie
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Patricia Kowsmann
narrative on The Journal.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Topics
Listen to This Episode
More from The Journal.
This Opioid Alternative Is Fueling an Addiction Crisis
How Big Food Is Navigating the GLP-1 Era
How Cocaine Is Flooding Into Europe
Weight-Loss Drugs Are Gobbling Up Small Town Budgets
What's Going On With Lettuce?
How Polymarket Made Fake Bets Go Viral
Related episodes
From other shows on similar topics.
Does the science of peptides live up to the hype?
Short Wave
The Booming Business of Chinese Peptides
Odd Lots
Peptides: The Ultimate Body Hack?
Science Vs
Pushing peptides
Today, Explained
How Peptides Conquered the Internet
Search Engine
A Flood of New, Deadlier Drugs
The Daily
Get summaries like this every morning.
Free AI-powered recaps of The Journal. and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.